Trinity Delta’s business is institutional quality issuer-paid equity research.

Our company coverage and past research notes can be accessed via the dedicated Company Pages below, or from our Research Library.

BerGenBio
BerGenBio is a clinical-stage, drug development company based in Norway and UK. It is developing novel oncology therapies by inhibiting AXL signalling.
Read more
Bonesupport
Bonesupport is a Swedish orthobiologics company with a pipeline of drug-eluting, bioceramic bone graft substitutes based on its CERAMENT technology.
Read more
Futura Medical
Futura Medical is an R&D driven small pharma with a novel DermaSys transdermal delivery system and a Phase III product (MED2005) for erectile dysfunction.
Read more
Hutchison China MediTech
Hutchison China MediTech, a Hong Kong-based biopharmaceutical company, developing and commercialising innovative, highly selective oral therapies for oncology indications.
Read more
Kind Consumer
Kind Consumer has developed a novel nicotine delivery device, Voke, that mimics the important aspects of cigarette smoking.
Read more
MaxCyte
MaxCyte has a patented flow electroporation platform for the transfection of a wide array of cells, and has a proprietary mRNA-mediated CAR technology, known as CARMA.
Read more
Mereo BioPharma
Mereo BioPharma develops and commercialises innovative therapies for rare diseases. These are acquired or licensed in at clinical stages from big pharma companies.
Read more
Nexstim
Nexstim is a targeted neuro-modulation company that has developed a proprietary navigated rTMS platform for use in diagnostics (NBS) and therapeutics (NBT).
Read more
Scancell
Scancell is a clinical-stage immuno-oncology specialist that is developing two innovative and flexible therapeutic vaccine platforms, ImmunoBody and Moditope.
Read more

Subscribe to our research

Please sign up here to be added to our distribution database.